A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 143

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 143
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 209
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 994
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3134
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 574
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 488
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer's disease. | LitMetric

We investigated the inhibitory activities of novel 9-phosphoryl-9,10-dihydroacridines and 9-phosphorylacridines against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and carboxylesterase (CES). We also studied the abilities of the new compounds to interfere with the self-aggregation of β-amyloid (Aβ) in the thioflavin test as well as their antioxidant activities in the ABTS and FRAP assays. We used molecular docking, molecular dynamics simulations, and quantum-chemical calculations to explain experimental results. All new compounds weakly inhibited AChE and off-target CES. Dihydroacridines with aryl substituents in the phosphoryl moiety inhibited BChE; the most active were the dibenzyloxy derivative and its diphenethyl bioisostere (IC = 2.90 ± 0.23 µM and 3.22 ± 0.25 µM, respectively). Only one acridine, , an analog of dihydroacridine, , was an effective BChE inhibitor (IC = 6.90 ± 0.55 μM), consistent with docking results. Dihydroacridines inhibited Aβ self-aggregation; and were the most active (58.9% ± 4.7% and 46.9% ± 4.2%, respectively). All dihydroacridines demonstrated high ABTS-scavenging and iron-reducing activities comparable to Trolox, but acridines were almost inactive. Observed features were well explained by quantum-chemical calculations. ADMET parameters calculated for all compounds predicted favorable intestinal absorption, good blood-brain barrier permeability, and low cardiac toxicity. Overall, the best results were obtained for two dihydroacridine derivatives and with dibenzyloxy and diphenethyl substituents in the phosphoryl moiety. These compounds displayed high inhibition of BChE activity and Aβ self-aggregation, high antioxidant activity, and favorable predicted ADMET profiles. Therefore, we consider and as lead compounds for further in-depth studies as potential anti-AD preparations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466253PMC
http://dx.doi.org/10.3389/fphar.2023.1219980DOI Listing

Publication Analysis

Top Keywords

antioxidant activity
8
quantum-chemical calculations
8
substituents phosphoryl
8
phosphoryl moiety
8
aβ self-aggregation
8
compounds
5
derivatives 9-phosphorylated
4
9-phosphorylated acridine
4
acridine butyrylcholinesterase
4
butyrylcholinesterase inhibitors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!